Cancer Summit

Emerging Therapies and Future Directions in Oncology

Emerging therapies in oncology are reshaping the future of cancer care by introducing novel treatment modalities, innovative drug platforms, and multi-disciplinary strategies aimed at improving efficacy, minimizing toxicity, and enhancing patient survival. Current trends include next-generation immunotherapies such as personalized cancer vaccines, bispecific antibodies, oncolytic viruses, and combination regimens that integrate immunotherapy with targeted therapy, chemotherapy, or radiotherapy to overcome resistance mechanisms. Advances in gene editing, including CRISPR-Cas9, and cell-based therapies are enabling precise manipulation of tumor and immune cells to enhance antitumor activity. Nanotechnology-based drug delivery systems are improving the bioavailability and tumor-specific targeting of chemotherapeutics and biologics, reducing systemic side effects. Artificial intelligence and predictive analytics are accelerating drug discovery, optimizing clinical trial design, and enabling real-time monitoring of treatment responses. In parallel, precision medicine initiatives leverage genomic, proteomic, and metabolomic profiling to develop patient-specific therapeutic strategies and identify high-risk populations for preventive interventions. Challenges such as regulatory complexities, high treatment costs, tumor heterogeneity, and equitable access remain, highlighting the need for global collaboration in research and healthcare delivery. This session will explore cutting-edge innovations, translational research, clinical trial advancements, and future perspectives that are poised to redefine oncology, offering hope for more durable responses, personalized therapies, and ultimately improved global cancer outcomes.